"As the capital markets evolve, OpenIPO will be a highly valuable tool for healthcare companies to access the public markets, and this collaboration continues our strategy to broaden the Merchant Banking services we provide to the industry."
"We are excited to be partnering with Steve," said Bill Hambrecht, Founder and CEO of WR Hambrecht + Co. "Burrill & Company is a top-notch organization and a world leader in biotech and life sciences. We have done several healthcare auctions and my investments in biotech go all the way back to Genentech. We think this partnership can take advantage of both of our strengths."
About Burrill Merchant Banking
Burrill Merchant Banking assists healthcare companies to identify, negotiate and close strategic transactions. Service lines include:
About Burrill & Company
Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media. The Burrill family of venture capital funds has over $1 billion under management and its merchant banking business is one of the industry leaders in life sciences transactions. Burrill is also the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publisher of a range of bio-intelligence reports including the monthly Burrill Report (www.burrillreport.com), which tracks the progress of the global biotechnology industry and annual "State of the Industry" report the latest of which is Biotech 2009-Life Sciences: Navigating the Sea Change, the 23rd annual report on the industry. The 470-plus page book contains analysis and perspectives on the performance of the industry in 2008 and projections for
|SOURCE Burrill & Company; WR Hambrecht + Co|
Copyright©2009 PR Newswire.
All rights reserved